Neurology News

The National Football League and the NFL Players Association have issued a joint statement finalizing review of the league’s concussion protocol, which now prohibits a player from returning to a game if diagnosed with ataxia.

LAS VEGAS — Cannabinoids have been shown to effectively control seizures across the epilepsy spectrum; however, quality control of products remains a challenge, according to a presenter at BRAINWeek 2022.

In this edition, lecanemab study shows reduction in clinical decline for early AD; multimorbidity associated with increased risk for dementia, Crenezumab not effective in treating Alzheimer's disease and more.

LAS VEGAS — Rapid reduction of symptoms and pain, achieved through the most effective drug and nondrug treatments, is a key priority for patients who experience acute migraines, according to a presenter at BRAINWeek 2022.

Treatment with sildenafil or tadalafil was not associated with a reduced risk for incident Alzheimer’s disease and related dementia in patients with pulmonary hypertension, according to a study published in Brain Communications.

LAS VEGAS — Aggressive screening, grading of injury and early initiation of antithrombotic therapy may reduce risk for stroke in patients with blunt cerebrovascular injury, according to a presenter at BRAINWeek 2022.

LAS VEGAS — To address patient need, affordability and physician-assisted treatment plans, a range of prevention therapies should be offered to those with migraines, according to a presenter at BRAINWeek 2022.

LAS VEGAS — Central neuropathic pain can be challenging to treat, but several pharmacologic and nonpharmacologic options are available, according to a presenter at BRAINWeek 2022.

The FDA has approved Relyvrio, an oral, fixed-dose combination therapy for the treatment of adults with ALS, Amylyx Pharmaceuticals Inc. announced in a press release.

The NIH has awarded a $10.7 million 5-year renewal grant to Cleveland Clinic to expand a national research consortium focused on improving the diagnosis and treatments for dementia with Lewy bodies.